Martino, M., Pitino, A., Gori, M., Viens, P., Siena, S., Tripepi, G., et al. (2022). Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study. BONE MARROW TRANSPLANTATION, 57(2), 276-278 [10.1038/s41409-021-01503-7].

Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study

Zambelli, Alberto;
2022

Lettera in rivista
Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Consolidation Chemotherapy; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Registries; Transplantation, Autologous
English
23-ott-2021
2022
57
2
276
278
reserved
Martino, M., Pitino, A., Gori, M., Viens, P., Siena, S., Tripepi, G., et al. (2022). Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study. BONE MARROW TRANSPLANTATION, 57(2), 276-278 [10.1038/s41409-021-01503-7].
File in questo prodotto:
File Dimensione Formato  
Martino-2022-Bone Marrow Transplantation-VoR.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 501.61 kB
Formato Adobe PDF
501.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/526862
Citazioni
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
Social impact